Page last updated: 2024-08-22

sodium arsenite and Granulocytic Leukemia, Chronic

sodium arsenite has been researched along with Granulocytic Leukemia, Chronic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Himeno, S; Ogawa, M; Ogawa, T; Sumi, D; Tsuyama, H1

Other Studies

1 other study(ies) available for sodium arsenite and Granulocytic Leukemia, Chronic

ArticleYear
Arsenite suppresses IL-2-dependent tumoricidal activities of natural killer cells.
    Toxicology and applied pharmacology, 2021, 02-01, Volume: 412

    Topics: Animals; Arsenites; Coculture Techniques; Cytotoxicity, Immunologic; Granzymes; Humans; Interferon-gamma; Interleukin-10; Interleukin-2; K562 Cells; Killer Cells, Natural; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphotoxin-alpha; Mice; Mice, Inbred C57BL; Receptors, KIR2DL2; Receptors, KIR2DL3; Sodium Compounds; Tumor Escape

2021